pharma · Atopic Dermatitis · Seborrheic Keratosis · ACRS
Aclaris Therapeutics
Aclipse Therapeutics is a pharma organization headquartered in Radnor Township, USA. It trades on NYSE under ticker ACRS. Primary therapeutic focus areas include Atopic Dermatitis, Seborrheic Keratosis, Common Wart, Alop
170 N Radnor Chester Rd, Radnor Township, Pennsylvania, US HQ
2012 Founded
10 Employees
Public company Type
ACRS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 170 N Radnor Chester Rd, Radnor Township, Pennsylvania, US
- Founded
- 2012
- Employees
- 10
- Programs
- 33
- Drugs
- 12
- Patents
- 18
ATI-045
Phase 2 · small molecule · Atopic Dermatitis
ATI-045 for Atopic Dermatitis is a Phase 2 program (small_molecule) at Aclaris Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code ATI-045-AD-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aclaris Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Atopic Dermatitis
- Status
- active
- Trials
- 1